Related Experiment Video
Updated: Jan 20, 2026

Streptozocin Treatment: A Zebrafish Model of Type 1 Diabetes Mellitus
Published on: April 30, 2023
Intervention in emotional abilities for adolescents with type 1 diabetes mellitus in a hospital setting: a study
Desiree Ruiz-Aranda1, Davinia M Resurrección2, Mencia R Gutierrez-Colosia1
1Psychology, Universidad Loyola Adalucia, Seville, Spain.
Introduction:
Type 1 diabetes mellitus (T1DM) is one of the most frequent chronic endocrine diseases in the paediatric population. As a result, this disease has a strong impact on psychological well-being. In line with this, emotional factors play an important role in adaptation. The aim of the present study protocol is to design an emotional abilities programme to improve metabolic control assessed by haemoglobin A1c (HbA1c) samples. Specifically, this intervention will be focused on adaptive coping strategies to deal with unpleasant emotions associated with T1DM. The primary aim of this project is to assess whether the employment of this new psychological intervention improves the emotional abilities of adolescents with T1DM.
Methods And Analysis:
Two focus groups will be carried out for the design and evaluation of the programme following the APEASE criteria (affordability, practicability, effectiveness, acceptability, side effects/safety and equity). Behavioural change will be based on the Behaviour Change Wheel. Sixty-two participants from 12 to 18 years of age will be recruited at a public hospital and randomised to either an intervention or a control group. The intervention group will receive an emotional abilities training programme. The control group will receive usual educational intervention. The primary outcomes are metabolic control and emotional abilities. The secondary outcomes include emotional distress control, positive and negative affect, healthy habits, and quality of life. Data will be collected at baseline, immediately postintervention, and at follow-up visits at 6 and 12 months. A feasibility analysis will be conducted.
Ethics And Dissemination:
The study has been approved by the Ethics Committee of Universidad Loyola Andalucía. Results will be submitted for publication in peer-reviewed journals and disseminated across the scientific community.
Trial Registration Number:
NCT03734367.
Related Concept Videos
04:26Streptozocin Treatment: A Zebrafish Model of Type 1 Diabetes Mellitus
Diabetes Mellitus: Type 2 and Gestational
10:03A Zebrafish Model of Diabetes Mellitus and Metabolic Memory
05:18A Protocol for Constructing a Rat Wound Model of Type 1 Diabetes
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
06:46A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19

